M Séligmann

6.9k total citations · 1 hit paper
194 papers, 5.2k citations indexed

About

M Séligmann is a scholar working on Immunology, Hematology and Genetics. According to data from OpenAlex, M Séligmann has authored 194 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Immunology, 55 papers in Hematology and 50 papers in Genetics. Recurrent topics in M Séligmann's work include Immunodeficiency and Autoimmune Disorders (60 papers), Chronic Lymphocytic Leukemia Research (45 papers) and Monoclonal and Polyclonal Antibodies Research (24 papers). M Séligmann is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (60 papers), Chronic Lymphocytic Leukemia Research (45 papers) and Monoclonal and Polyclonal Antibodies Research (24 papers). M Séligmann collaborates with scholars based in France, United States and Tunisia. M Séligmann's co-authors include J L Preud'homme, J C Brouet, J C Brouet, Brouet Jc, Jean‐Louis Preud'homme, F Danon, Georges Flandrin, A Cannat, W. H. Hitzig and H. Hugh Fudenberg and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

M Séligmann

175 papers receiving 4.3k citations

Hit Papers

Surface Bound Immunoglobu... 1972 2026 1990 2008 1972 100 200 300 400

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
M Séligmann 2.3k 1.7k 1.4k 1.0k 1000 194 5.2k
Maxime Seligmann 1.8k 0.8× 1.4k 0.8× 908 0.7× 946 0.9× 1.0k 1.0× 70 4.9k
Alan C. Aisenberg 1.7k 0.7× 1.5k 0.9× 465 0.3× 2.6k 2.6× 817 0.8× 133 6.0k
G Jánossy 1.6k 0.7× 740 0.4× 1.2k 0.9× 459 0.5× 781 0.8× 59 3.5k
A. E. G. Kr. von dem Borne 2.4k 1.0× 1.0k 0.6× 3.9k 2.9× 456 0.4× 1.1k 1.1× 211 7.5k
JG Gribben 2.5k 1.1× 825 0.5× 887 0.6× 1.1k 1.1× 662 0.7× 57 4.3k
Paul L. Weiden 2.4k 1.0× 982 0.6× 5.1k 3.7× 540 0.5× 516 0.5× 105 7.6k
Vincent Agnello 2.4k 1.0× 1.1k 0.6× 672 0.5× 743 0.7× 813 0.8× 85 7.1k
S Slavin 2.5k 1.1× 682 0.4× 3.1k 2.2× 567 0.6× 574 0.6× 186 5.7k
Hendrik Veelken 2.4k 1.0× 1.3k 0.7× 1.3k 0.9× 1.4k 1.3× 1.7k 1.7× 181 5.6k
Antonio Pezzutto 2.0k 0.9× 669 0.4× 917 0.7× 763 0.7× 871 0.9× 158 4.0k

Countries citing papers authored by M Séligmann

Since Specialization
Citations

This map shows the geographic impact of M Séligmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Séligmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Séligmann more than expected).

Fields of papers citing papers by M Séligmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Séligmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Séligmann. The network helps show where M Séligmann may publish in the future.

Co-authorship network of co-authors of M Séligmann

This figure shows the co-authorship network connecting the top 25 collaborators of M Séligmann. A scholar is included among the top collaborators of M Séligmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Séligmann. M Séligmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lévy, Yves, Catherine Capitant, Sami Houhou, et al.. (1999). Comparison of subcutaneous and intravenous interleukin-2 in asymptomatic HIV-1 infection: a randomised controlled trial. The Lancet. 353(9168). 1923–1929. 116 indexed citations
2.
Darbyshire, JH, et al.. (1994). CONCORDE TRIAL OF IMMEDIATE VERSUS DEFERRED ZIDOVUDINE - REPLY. The Lancet.
3.
Séligmann, M. (1993). Maladies des chaînes lourdes.. La Revue du praticien. 43(3). 5 indexed citations
4.
Oksenhendler, Éric, M Séligmann, JP Clauvel, et al.. (1992). CD8 lymphocytosis and pseudotumoral splenomegaly in HIV infection. The Lancet. 340(8813). 207–208. 18 indexed citations
5.
Fermand, JP, J Gerota, M Benbunan, et al.. (1989). Treatment of aggressive multiple myeloma by high-dose chemotherapy and total body irradiation followed by blood stem cells autologous graft. Blood. 73(1). 20–23. 4 indexed citations
6.
Séligmann, M. (1979). [Lymphoplasmocyte hemopathies and current data on monoclonal proliferations of B cells].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 29(3). 295–9. 2 indexed citations
7.
Bender, S. W., et al.. (1978). Gamma heavy chain disease simulating alpha chain disease.. Gut. 19(12). 1148–1152. 11 indexed citations
8.
Loyau, G, et al.. (1977). Maladie des chaînes lourdes gamma. Une nouvelle observation avec prolifération plasmocytaire et lacunes crâniennes. 128(2). 3 indexed citations
9.
Brouet, J C, et al.. (1976). Membrane Markers in “Histiocytic” Lymphomas (Reticulum Cell Sarcomas) 2. JNCI Journal of the National Cancer Institute. 56(3). 631–633. 159 indexed citations
10.
Séligmann, M, C Griscelli, J L Preud'homme, et al.. (1975). Severe combined immunodeficiency with B lymphocytes and with normal MLC response.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 11(1). 154–7. 8 indexed citations
11.
Séligmann, M. (1975). Alpha-chain disease.. Journal of Clinical Pathology. s1-6(1). 72–76. 7 indexed citations
12.
Tursz, Thomas, Georges Flandrin, J C Brouet, Josette Brière, & M Séligmann. (1974). Simultaneous Occurrence of Acute Myeloblastic Leukaemia and Multiple Myeloma without Previous Chemotherapy. BMJ. 2(5920). 642–643. 44 indexed citations
13.
Brouet, J C, et al.. (1973). Déficit immunitaire avec nanisme compliqué d'un réticulosarcome chez deux soeurs. 30(6). 3 indexed citations
14.
Cannat, A & M Séligmann. (1973). Immunological Abnormalities in Juvenile Myelomonocytic Leukaemia. BMJ. 1(5845). 71–74. 21 indexed citations
15.
Preud'homme, J L & M Séligmann. (1972). Anti-Human Immunoglobulin G Activity of Membrane-Bound Monoclonal Immunoglobulin M in Lymphoproliferative Disorders. Proceedings of the National Academy of Sciences. 69(8). 2132–2135. 104 indexed citations
16.
Preud'homme, J L, Manuela Poletto Klein, P Verroust, & M Séligmann. (1971). Immunoglobulines monoclonales de membrane dans les leucémies lymphoïdes chroniques.. 16(10). 14 indexed citations
17.
Séligmann, M, F Danon, & Jean‐Pierre Clauvel. (1971). Natural history of monoclonal immunoglobulins.. BMJ. 2(5757). 321.2–322. 10 indexed citations
18.
Yount, William J., Robert Hong, M Séligmann, R GOOD, & Henry G. Kunkel. (1970). Imbalances of gamma globulin subgroups and gene defects in patients with primary hypogammaglobulinemia. Journal of Clinical Investigation. 49(11). 1957–1966. 113 indexed citations
19.
Séligmann, M, et al.. (1969). The British Society of Gastroenterology. Gut. 10(5). 413–416. 11 indexed citations
20.
Cannat, A & M Séligmann. (1966). POSSIBLE INDUCTION OF ANTINUCLEAR ANTIBODIES BY ISONIAZID. The Lancet. 287(7430). 185–187. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026